VanEck Biotech ETF (BBH)
NasdaqGM: BBH
· Real-Time Price · USD
224.48
+2.20 (0.99%)
At close: Aug 18, 2026, 3:57 PM
VanEck Biotech ETF (BBH) Stock Price, Analysis & Data
0.99% (1D)
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 27.61 |
| Forward PE | n/a |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 5,927 |
| Avg. Volume (20D) | 4,932 |
| Open | 224.27 |
| Previous Close | 222.28 |
| Day's Range | 224.27 - 225.18 |
| 52-Week Range | 160.91 - 225.25 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified....
Industry n/a
Sector n/a
IPO Date Nov 23, 1999
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol BBH
Financial Performance
In undefined, VanEck Biotech ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements
